Preloader
Conferences Mind conferences are accredited with Continuing Professional Development (CPD) and Continuing Education (CE), Continuing Medical Education (CME) credits respectively. This is the best platform of the worldwide Conferences, Symposia, Workshops and Exhibitions, include all major science (Medical, Clinical, Pharma, Life Science), Technology (Robotics, Mechatronics), Business Management and Engineering.

Welcome To
Global Conference on

Covid 19 - Immunology & Immunodeficiency

THEME: Covid-19 Fighting with Invisible Virus
WEBINAR: International Web Conference
December 07-09, 2020
CONFERENCE: San Diego, USA

Global Conference on “Covid 19 - Immunology & Immunodeficiency” which is scheduled during December 07-09, 2020.  Most Countries around the World have faced cases of COVID-19 and many are experiencing outbreaks. However, the situation is unpredictable therefore Global Covid-19 2020 team  welcomes everyone worldwide to be a part of WEBINAR: International Web Conference. This International Web Conference provides an E-learning opportunity and to contribute your big Idea to shape the future for achieving better health for all, We request you all to  showcase you recent research and advancement in the field of Covid-19(Corona Virus) as a Global Respond. This Web Conference gives a forum to interactive and encourages a level of discussion about the recent pandemic Covid -19 Virus. This is the best Web platform to showcase Your’s recent research innovations which will reach millions of health workers and others worldwide through International Web Conference and gain new information which is able to be valuable for growth within the field of generating new plans and ideas to reinforce yourself and your skilled profession. Global Covid-19 2020 Conference focused on the theme: “Covid-19 Fighting with Invisible Virus”.

Read more

Track 1. Covid-19 (Corona Virus):

'CO' stands for corona, 'VI' for virus, and 'D' for disease. The COVID-19 virus spreads principally through droplets of saliva or discharge from the nostril when an infected individual coughs or sneezes, Coronaviruses are a group of viruses that are recognized to cause sickness ranging from the frequent cold to greater extreme diseases such as Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS). The exceptional way to stop and sluggish down transmission is to guard yourself and others from contamination through washing your palms or the usage of an alcohol based totally rub often and no longer touching your face.

Related Association & Societies:

World Allergy Organization | The American Autoimmune Related Diseases Association | The International Society of Neuroimmunology | Indian Immunology Society |Cell Death Society | Federation of Clinical Immunology Societies | Immune Deficiency Foundation | Society of Mucosal Immunology | British Society for Immunology | American Association of Immunologists | International Union of Immunological Societies | European Academy of Allergy and Clinical Immunology | Australasian Society of Clinical Immunology and Allergy | National Institute of Immunology India | American Society for Reproductive Immunology | La Jolla Institute for Immunology | Society for Immunotherapy of Cancer | Basel Institute for Immunology | Society Austrian Society for Allergology and Immunology

Vaccination Organizations:

Bharat Biotech’s | Centers for Disease Control and Prevention | Oxford Vaccine Group | Moderna | Dynavax | Geovax | Curevac | BioNTech | Novavax Inc | Inovio Pharmaceuticals | Pfizer | GlaxoSmithKline | Gavi the Vaccine Alliance | National Vaccine Information Center | Immunization Action Coalition | National Center for Immunization and Respiratory Diseases | National Foundation for Infectious Diseases | Sabin Vaccine Institute | Infectious Diseases Society of America | American Immunization Registry Association | Hepatitis B Foundation | National Academy of Medicine | Public Health Agency of Canada | American College of Nurse Midwives | American Medical Association | Indian Medical Association

Track 2. SARS-CoV-2:

SARS-CoV-2 is a coronavirus that causes coronavirus disease (COVID-19). SARS-CoV-2 mainly seems to travel from person to person. However, some questions about its transmission remain unanswered. According to their specific characteristics, there are four main ranks, or genera, of coronavirus: alpha, beta, delta, and gamma. Most of only affect animals, but a few can also pass to humans. Those that are transmissible to humans belong to only two of these genera: alpha and beta.

Related Association & Societies:

World Allergy Organization | The American Autoimmune Related Diseases Association | The International Society of Neuroimmunology | Indian Immunology Society |Cell Death Society | Federation of Clinical Immunology Societies | Immune Deficiency Foundation | Society of Mucosal Immunology | British Society for Immunology | American Association of Immunologists | International Union of Immunological Societies | European Academy of Allergy and Clinical Immunology | Australasian Society of Clinical Immunology and Allergy | National Institute of Immunology India | American Society for Reproductive Immunology | La Jolla Institute for Immunology | Society for Immunotherapy of Cancer | Basel Institute for Immunology | Society Austrian Society for Allergology and Immunology

Vaccination Organizations:

Bharat Biotech’s | Centers for Disease Control and Prevention | Oxford Vaccine Group | Moderna | Dynavax | Geovax | Curevac | BioNTech | Novavax Inc | Inovio Pharmaceuticals | Pfizer | GlaxoSmithKline | Gavi the Vaccine Alliance | National Vaccine Information Center | Immunization Action Coalition | National Center for Immunization and Respiratory Diseases | National Foundation for Infectious Diseases | Sabin Vaccine Institute | Infectious Diseases Society of America | American Immunization Registry Association | Hepatitis B Foundation | National Academy of Medicine | Public Health Agency of Canada | American College of Nurse Midwives | American Medical Association | Indian Medical Association

Track 3. Immunology and Immune System response in Covid-19:

Immunology is the study of the immune system and is a very vital branch of the clinical and biological sciences. The immune system protects us from contamination through various lines of defense. If the immune device is no longer functioning as it should, it can result in disease, such as autoimmunity, allergic reaction and cancer. It is additionally now turning into clear that immune responses make a contribution to the improvement of many frequent problems not traditionally viewed as immunologic, including metabolic, cardiovascular, and neurodegenerative stipulations such as Alzheimer’s. The immune system is a complicated system of structures and strategies that has advanced to guard us from disease. Molecular and cellular aspects make up the immune system. The characteristic of these elements is divided up into nonspecific mechanisms, these which are innate to an organism, and responsive responses, which are adaptive to specific pathogens. Fundamental or classical immunology involves analyzing the aspects that make up the innate and adaptive immune system.

Immune response to Covid-19 involves both cell-mediated immunity and antibody production:

Cell-mediated Immune response:

T-cell responses towards SARS-CoV-2 spike protein have been characterized and correspond properly with IgG and IgA antibody titres in COVID-19 patients, which has essential implications for vaccine design and long-term immune response. It is presently unknown whether or not antibody responses or T-cell responses in infected human beings confer shielding immunity, and if so, how sturdy response is needed for this to occur. CD8+ T cells are the principal inflammatory cells and play a vital position in virus clearance. Total lymphocytes, CD4+ T cells, CD8+ T cells, B cells, and natural killer cells confirmed a great association with inflammatory popularity in COVID-19, in particular CD8+ T cells and CD4+/CD8+ ratio. Decreased absolute numbers of T lymphocytes, CD4+ T cells, and CD8+ T cells had been observed in each slight cases and extreme cases, however accentuated in the severe cases.

Antibody-mediated immune response and protective immunity:

The detection of antibodies to SARS-CoV-2 does not indicate immediately protective immunity and correlates of safety for COVID-19 have no longer yet been established. Most persons contaminated with SARS-CoV-2 show an antibody response between day 10 and day 21 after infection. Detection in moderate instances can take longer time four weeks or more and in a small wide variety of instances antibodies (i.e., IgM, IgG) are not detected at all at least during the studies’ time scale. The IgM and IgG antibodies to SARS-CoV-2 enhance between 6–15 days post disease onset. The median seroconversion time for total antibodies, IgM and then IgG have been day-11, day-12 and day-14 post symptom onset, respectively. The presence of antibodies used to be detected in <40% amongst sufferers inside 1 week from onset, and rapidly extended to 100% (total antibodies), 94.3% (IgM) and 79.8% (IgG) from day-15 after onset.

The durability of the antibody response is still unknown; however, it is recognized that antibodies to different coronaviruses wane over time range: 12 – 52 weeks from the onset of signs and homologous re-infections have been shown. SARS-CoV-2 IgM and IgG antibody levels may also stay over the path of seven weeks or at least in 80% of the cases till day 49. In comparison, 90% and 50% of SARS-CoV-1 contaminated patients have been proven to hold IgG antibodies for two and three years respectively. In addition, it could be vital to discover nasal IgA antibodies, as the serum IgA antibodies were not raised, but IgA persisted in the nasal mucosa one-year post-infection for seasonal coronavirus 229E.

Related Association & Societies:

World Allergy Organization | The American Autoimmune Related Diseases Association | The International Society of Neuroimmunology | Indian Immunology Society |Cell Death Society | Federation of Clinical Immunology Societies | Immune Deficiency Foundation | Society of Mucosal Immunology | British Society for Immunology | American Association of Immunologists | International Union of Immunological Societies | European Academy of Allergy and Clinical Immunology | Australasian Society of Clinical Immunology and Allergy | National Institute of Immunology India | American Society for Reproductive Immunology | La Jolla Institute for Immunology | Society for Immunotherapy of Cancer | Basel Institute for Immunology | Society Austrian Society for Allergology and Immunology

Vaccination Organizations:

Bharat Biotech’s | Centers for Disease Control and Prevention | Oxford Vaccine Group | Moderna | Dynavax | Geovax | Curevac | BioNTech | Novavax Inc | Inovio Pharmaceuticals | Pfizer | GlaxoSmithKline | Gavi the Vaccine Alliance | National Vaccine Information Center | Immunization Action Coalition | National Center for Immunization and Respiratory Diseases | National Foundation for Infectious Diseases | Sabin Vaccine Institute | Infectious Diseases Society of America | American Immunization Registry Association | Hepatitis B Foundation | National Academy of Medicine | Public Health Agency of Canada | American College of Nurse Midwives | American Medical Association | Indian Medical Association

Track 4. Medical education: COVID ?19 and surgery:

The COVID?19 pandemic will continue to have a major impact on surgical practice, with guidance within hospitals needed urgently. There is a clear need for social distancing, and this is the most effective mitigative measure until a vaccine or antiviral medication is found. As such, much of teaching has already transitioned to an online platform. However, surgery is an art that can only be perfected in the operating theatre. Learning about the various instruments involved, the roles of the multidisciplinary team, and the steps that clinicians take throughout the patient journey to ensure patient safety, is best experienced. It may well be time to reform the medium of delivering surgical education.

Related Association & Societies:

World Allergy Organization | The American Autoimmune Related Diseases Association | The International Society of Neuroimmunology | Indian Immunology Society |Cell Death Society | Federation of Clinical Immunology Societies | Immune Deficiency Foundation | Society of Mucosal Immunology | British Society for Immunology | American Association of Immunologists | International Union of Immunological Societies | European Academy of Allergy and Clinical Immunology | Australasian Society of Clinical Immunology and Allergy | National Institute of Immunology India | American Society for Reproductive Immunology | La Jolla Institute for Immunology | Society for Immunotherapy of Cancer | Basel Institute for Immunology | Society Austrian Society for Allergology and Immunology

Vaccination Organizations:

Bharat Biotech’s | Centers for Disease Control and Prevention | Oxford Vaccine Group | Moderna | Dynavax | Geovax | Curevac | BioNTech | Novavax Inc | Inovio Pharmaceuticals | Pfizer | GlaxoSmithKline | Gavi the Vaccine Alliance | National Vaccine Information Center | Immunization Action Coalition | National Center for Immunization and Respiratory Diseases | National Foundation for Infectious Diseases | Sabin Vaccine Institute | Infectious Diseases Society of America | American Immunization Registry Association | Hepatitis B Foundation | National Academy of Medicine | Public Health Agency of Canada | American College of Nurse Midwives | American Medical Association | Indian Medical Association

Track 5. Covid-19 impact on Gynecological Cancers:

Abdominal pain is also part of the symptom complex of most gynecological cancers, especially uterus and ovary, switching these patients to open surgery will likely worsen surgical outcomes and increase potential exposure to COVID?19 in the postoperative period. Cancer guidelines are being modified and prioritized due to the restrictions imposed. Minimally invasive surgery (either laparoscopic or robotic) is associated with reduced length of stay, reduced need for intensive care support, reduced blood loss and enhanced recovery. Surgeons are currently in the midst of a delicate balancing act of protecting our patients from COVID?19 and providing timely treatment of their cancer.

Related Association & Societies:

World Allergy Organization | The American Autoimmune Related Diseases Association | The International Society of Neuroimmunology | Indian Immunology Society |Cell Death Society | Federation of Clinical Immunology Societies | Immune Deficiency Foundation | Society of Mucosal Immunology | British Society for Immunology | American Association of Immunologists | International Union of Immunological Societies | European Academy of Allergy and Clinical Immunology | Australasian Society of Clinical Immunology and Allergy | National Institute of Immunology India | American Society for Reproductive Immunology | La Jolla Institute for Immunology | Society for Immunotherapy of Cancer | Basel Institute for Immunology | Society Austrian Society for Allergology and Immunology

Vaccination Organizations:

Bharat Biotech’s | Centers for Disease Control and Prevention | Oxford Vaccine Group | Moderna | Dynavax | Geovax | Curevac | BioNTech | Novavax Inc | Inovio Pharmaceuticals | Pfizer | GlaxoSmithKline | Gavi the Vaccine Alliance | National Vaccine Information Center | Immunization Action Coalition | National Center for Immunization and Respiratory Diseases | National Foundation for Infectious Diseases | Sabin Vaccine Institute | Infectious Diseases Society of America | American Immunization Registry Association | Hepatitis B Foundation | National Academy of Medicine | Public Health Agency of Canada | American College of Nurse Midwives | American Medical Association | Indian Medical Association

Track 6. Identifying Potential Risks and Sources of Exposure:

In assessing potential hazards, employers should consider if and when their workers may encounter someone infected with SARS-CoV-2 in the course of their duties. Employers should also determine if workers could be exposed to environments (e.g., work sites) or materials (e.g., laboratory samples, waste) contaminated with the virus. Depending on the work setting, employers may also rely on the identification of sick individuals who have signs, symptoms, and/or a history of travel to COVID-19 affected areas, to assist pick out publicity dangers for people and put in force suitable manage measures.

Related Association & Societies:

World Allergy Organization | The American Autoimmune Related Diseases Association | The International Society of Neuroimmunology | Indian Immunology Society |Cell Death Society | Federation of Clinical Immunology Societies | Immune Deficiency Foundation | Society of Mucosal Immunology | British Society for Immunology | American Association of Immunologists | International Union of Immunological Societies | European Academy of Allergy and Clinical Immunology | Australasian Society of Clinical Immunology and Allergy | National Institute of Immunology India | American Society for Reproductive Immunology | La Jolla Institute for Immunology | Society for Immunotherapy of Cancer | Basel Institute for Immunology | Society Austrian Society for Allergology and Immunology

Vaccination Organizations:

Bharat Biotech’s | Centers for Disease Control and Prevention | Oxford Vaccine Group | Moderna | Dynavax | Geovax | Curevac | BioNTech | Novavax Inc | Inovio Pharmaceuticals | Pfizer | GlaxoSmithKline | Gavi the Vaccine Alliance | National Vaccine Information Center | Immunization Action Coalition | National Center for Immunization and Respiratory Diseases | National Foundation for Infectious Diseases | Sabin Vaccine Institute | Infectious Diseases Society of America | American Immunization Registry Association | Hepatitis B Foundation | National Academy of Medicine | Public Health Agency of Canada | American College of Nurse Midwives | American Medical Association | Indian Medical Association

Track 7. Solid Waste and Wastewater Management general interim guidance to increased risk of occupational exposure to SARS-CoV-2 :

Municipal Waste:

Workers and employers ought to control municipal (e.g., household, business) solid waste with doable or recognized SARS-CoV-2 illness like any different non-contaminated municipal waste. Use regular engineering and administrative controls, protected work practices, and PPE, such as puncture-resistant gloves and face and eye protection, to stop employee exposure to the waste streams (or kinds of wastes), along with any contaminants in the materials, they manage.

Medical Waste:

Medical waste with doable or regarded COVID-19 contamination, control like any different regulated clinical waste. COVID-19 is now not a Category A infectious substance. For regulated clinical waste information, seek advice from the regulated clinical waste information in CDC's Guidelines for Environmental Infection Control in Health-Care Facilities. This record gives extra data associated to the administration of waste streams from hospitals and different healthcare facilities.

Wastewater:

Coronaviruses are prone to the identical disinfection conditions in the healthcare placing as different viruses, so present-day disinfection prerequisites in wastewater cure facilities are predicted to be sufficient. This consists of stipulations for practices such as oxidation with hypochlorite (i.e., chlorine bleach) and peracetic acid, as nicely as inactivation through the use of ultraviolet irradiation. There is no proof to advise that additional, COVID-19 specific protections are wished for personnel worried in wastewater administration operations, inclusive of these at wastewater cure facilities. Wastewater therapy plant operations have to make certain people observe hobbies practices to forestall exposure to wastewater, which includes the usage of the engineering and administrative controls, safe work practices, and required for work duties when dealing with untreated wastewater.

Related Association & Societies:

World Allergy Organization | The American Autoimmune Related Diseases Association | The International Society of Neuroimmunology | Indian Immunology Society |Cell Death Society | Federation of Clinical Immunology Societies | Immune Deficiency Foundation | Society of Mucosal Immunology | British Society for Immunology | American Association of Immunologists | International Union of Immunological Societies | European Academy of Allergy and Clinical Immunology | Australasian Society of Clinical Immunology and Allergy | National Institute of Immunology India | American Society for Reproductive Immunology | La Jolla Institute for Immunology | Society for Immunotherapy of Cancer | Basel Institute for Immunology | Society Austrian Society for Allergology and Immunology

Vaccination Organizations:

Bharat Biotech’s | Centers for Disease Control and Prevention | Oxford Vaccine Group | Moderna | Dynavax | Geovax | Curevac | BioNTech | Novavax Inc | Inovio Pharmaceuticals | Pfizer | GlaxoSmithKline | Gavi the Vaccine Alliance | National Vaccine Information Center | Immunization Action Coalition | National Center for Immunization and Respiratory Diseases | National Foundation for Infectious Diseases | Sabin Vaccine Institute | Infectious Diseases Society of America | American Immunization Registry Association | Hepatitis B Foundation | National Academy of Medicine | Public Health Agency of Canada | American College of Nurse Midwives | American Medical Association | Indian Medical Association

Track 8. COVID-19 Treatment:

Till now no vaccine or specific treatment for COVID-19 is available. Hospitals can provide supportive care for people who have serious cases of COVID-19. Anyone can become infected with SARS-CoV-19, however, those with a higher risk of severe illness should exercise additional caution. People who have serious underlying medical conditions, such as heart or lung disease or diabetes, may be at increased risk of complications from COVID-19.

Related Association & Societies:

World Allergy Organization | The American Autoimmune Related Diseases Association | The International Society of Neuroimmunology | Indian Immunology Society |Cell Death Society | Federation of Clinical Immunology Societies | Immune Deficiency Foundation | Society of Mucosal Immunology | British Society for Immunology | American Association of Immunologists | International Union of Immunological Societies | European Academy of Allergy and Clinical Immunology | Australasian Society of Clinical Immunology and Allergy | National Institute of Immunology India | American Society for Reproductive Immunology | La Jolla Institute for Immunology | Society for Immunotherapy of Cancer | Basel Institute for Immunology | Society Austrian Society for Allergology and Immunology

Vaccination Organizations:

Bharat Biotech’s | Centers for Disease Control and Prevention | Oxford Vaccine Group | Moderna | Dynavax | Geovax | Curevac | BioNTech | Novavax Inc | Inovio Pharmaceuticals | Pfizer | GlaxoSmithKline | Gavi the Vaccine Alliance | National Vaccine Information Center | Immunization Action Coalition | National Center for Immunization and Respiratory Diseases | National Foundation for Infectious Diseases | Sabin Vaccine Institute | Infectious Diseases Society of America | American Immunization Registry Association | Hepatitis B Foundation | National Academy of Medicine | Public Health Agency of Canada | American College of Nurse Midwives | American Medical Association | Indian Medical Association

Safety Guidance:

  •  Frequently Wash your hands with soap and water for 20 seconds. When soap and running water are unavailable, use an alcohol-based hand rub with at least 60% alcohol.
  • Avoid touching your body areas like eyes, nose, or mouth with unwashed hands, Practice good respiratory etiquette, including covering coughs and sneezes.
  • Maintain distance with people who are sick and Stay home if you are sick.
  • Certain people, including older adults and those with underlying conditions such as heart or lung disease or diabetes, are at higher risk for developing more serious complications from COVID-19.

Track 9. R&D Blueprint (COVID-19):

The R&D Blueprint works on the basis of a listing of identified precedence diseases. These are diseases that pose a public health risk due to the fact of their epidemic viable and for which there are no, or insufficient, countermeasures. R&D Blueprint is an international method and preparedness plan that permits the rapid activation of R&D things to do at some point of epidemics. Its aims are to fast-track the availability of high-quality tests, vaccines and drug treatments that can be used to save lives and avoid massive scale crisis. R&D Blueprint has been activated to speed up diagnostics , vaccines and therapeutics for this novel coronavirus (COVID-19).

Related Association & Societies:

World Allergy Organization | The American Autoimmune Related Diseases Association | The International Society of Neuroimmunology | Indian Immunology Society |Cell Death Society | Federation of Clinical Immunology Societies | Immune Deficiency Foundation | Society of Mucosal Immunology | British Society for Immunology | American Association of Immunologists | International Union of Immunological Societies | European Academy of Allergy and Clinical Immunology | Australasian Society of Clinical Immunology and Allergy | National Institute of Immunology India | American Society for Reproductive Immunology | La Jolla Institute for Immunology | Society for Immunotherapy of Cancer | Basel Institute for Immunology | Society Austrian Society for Allergology and Immunology

Vaccination Organizations:

Bharat Biotech’s | Centers for Disease Control and Prevention | Oxford Vaccine Group | Moderna | Dynavax | Geovax | Curevac | BioNTech | Novavax Inc | Inovio Pharmaceuticals | Pfizer | GlaxoSmithKline | Gavi the Vaccine Alliance | National Vaccine Information Center | Immunization Action Coalition | National Center for Immunization and Respiratory Diseases | National Foundation for Infectious Diseases | Sabin Vaccine Institute | Infectious Diseases Society of America | American Immunization Registry Association | Hepatitis B Foundation | National Academy of Medicine | Public Health Agency of Canada | American College of Nurse Midwives | American Medical Association | Indian Medical Association

Track 10. SARS-CoV-2 Compare with Other Coronaviruses:

Just like there are different kinds of related viruses that cause smallpox, chickenpox, and monkeypox, specific coronaviruses cause extraordinary illnesses in people. The Severe Acute Respiratory Syndrome (SARS) coronavirus causes SARS and the Middle East Respiratory Syndrome (MERS) coronavirus causes MERS. The novel coronavirus accountable for the contemporary pandemic, SARS-CoV-2, is one of seven types of recognized human coronaviruses. SARS-CoV-2, like the MERS and SARS coronaviruses, likely developed from a virus until now found in animals. The final known coronaviruses cause a significant proportion of colds in adults and children, and these are no longer a serious threat for otherwise healthy adults.

Related Association & Societies:

World Allergy Organization | The American Autoimmune Related Diseases Association | The International Society of Neuroimmunology | Indian Immunology Society |Cell Death Society | Federation of Clinical Immunology Societies | Immune Deficiency Foundation | Society of Mucosal Immunology | British Society for Immunology | American Association of Immunologists | International Union of Immunological Societies | European Academy of Allergy and Clinical Immunology | Australasian Society of Clinical Immunology and Allergy | National Institute of Immunology India | American Society for Reproductive Immunology | La Jolla Institute for Immunology | Society for Immunotherapy of Cancer | Basel Institute for Immunology | Society Austrian Society for Allergology and Immunology

Vaccination Organizations:

Bharat Biotech’s | Centers for Disease Control and Prevention | Oxford Vaccine Group | Moderna | Dynavax | Geovax | Curevac | BioNTech | Novavax Inc | Inovio Pharmaceuticals | Pfizer | GlaxoSmithKline | Gavi the Vaccine Alliance | National Vaccine Information Center | Immunization Action Coalition | National Center for Immunization and Respiratory Diseases | National Foundation for Infectious Diseases | Sabin Vaccine Institute | Infectious Diseases Society of America | American Immunization Registry Association | Hepatitis B Foundation | National Academy of Medicine | Public Health Agency of Canada | American College of Nurse Midwives | American Medical Association | Indian Medical Association

Read more

  • Track 1 : Covid-19 (Corona Virus)
  • Track 2 : SARS-CoV-2
  • Track 3 : Medical education: COVID ?19 and surgery
  • Track 4 : Covid-19 impact on Gynecological Cancers
  • Track 5 : Identifying Potential Risks and Sources of Exposure
  • Track 6 : Solid Waste and Wastewater Management general interim guidance to increased risk of occupational exposure to SARS-CoV-2
  • Track 7 : COVID-19 Treatment
  • Track 8 : R&D Blueprint (COVID-19)
  • Track 9 : SARS-CoV-2 Compare with Other Coronaviruses
  • Track 10 : Covid-19 pandemic impact on Anti-Microbial Resistance (AMR)
  • Track 11 : Coronavirus disease 2019 (COVID-19): Epidemiology, Virology, and it’s Prevention:

Read more

Organizing Committee

Rodolfo Javier Gordillo De Anda

Rodolfo Javier Gordillo De Anda

Nephroinmunologist

Hospital Medica Sur, Mexico

Umesh Prabhu

Umesh Prabhu

Medical Director

Bury NHS Trust, UK

Mirey Karavetian

Mirey Karavetian

Associate Professor

Zayed University, UAE

Rajinder Yadav

Rajinder Yadav

Director

Fortis Hospital, India

Dr. Azizollah Arbabisarjou

Dr. Azizollah Arbabisarjou

Associate Professor

Zahedan University of Medical Sciences, Iran

Dr. Andrew Lobashevsky

Dr. Andrew Lobashevsky

Director

Indiana University Health, USA

Dr. Naohiko Ueno

Dr. Naohiko Ueno

Director

Ueno Internal Medicine and Diabetes Clinic, Japan

Speakers

Sponsors Media Partners And Collaborators

Speak directly to one of our conference representatives by calling.

+91 7735912022
+91-7735912022

E-mail us your questions about the conference. We will respond to your questions.

academic@conferencemind.com

Sponsors / Exhibiting / Advertising

contact@conferencemind.com